Effect of hypoxia and TP53 mutation status and cytogenetics of normal and malignant mammary epithelium
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Jónasson, Jón Gunnlaugur
Ogmundsdóttir, Helga M
MetadataShow full item record
CitationCancer Genet. Cytogenet. 2006, 165(2):144-50
AbstractIt has been proposed that hypoxia favors the growth of tumor cells over normal cells, particularly tumor cells carrying TP53 mutations. Cytogenetic studies of breast cancer have shown that highly complex karyotypes seen in direct harvest preparations are rarely detected after short-term culture. In this study, 34 paired samples of breast carcinomas and grossly nontumorous tissue from the same breast were cultured at 20 and 5% (12 samples) or 20 and 0% oxygen (22 samples). Both carcinoma samples and nontumorous tissue survived at 0% oxygen. Recovery for 24 hours at 20% produced good yields for cytogenetic analysis. Lower oxygen levels did not specifically stimulate growth of tumor cells. Samples with TP53 mutations showed a consistently increased growth under anaerobic hypoxic conditions. Culture at 5% oxygen did not generally reveal more karyotypic abnormalities than found at 20%. In the samples cultured at 0 and 20%, karyotypic abnormalities were detected only in anaerobic hypoxic culture in two cases. Of the only four samples where more complex karyotypes were detected in the low-oxygen culture, two were TP53 mutated. Hypoxic treatment followed by recovery at 20% oxygen may thus increase the yield of complex karyotypes from a subset of breast carcinomas, particularly those with mutated TP53.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
- Authors: Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J
- Issue date: 2008
- High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
- Authors: Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J
- Issue date: 2009 Apr 15
- TP53 and breast cancer.
- Authors: Børresen-Dale AL
- Issue date: 2003 Mar
- Characterization of a new cytogenetic subtype of ductal breast carcinomas.
- Authors: Molist R, Remvikos Y, Dutrillaux B, Muleris M
- Issue date: 2004 Aug 5
- Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.
- Authors: Bertheau P, Turpin E, Rickman DS, Espié M, de Reyniès A, Feugeas JP, Plassa LF, Soliman H, Varna M, de Roquancourt A, Lehmann-Che J, Beuzard Y, Marty M, Misset JL, Janin A, de Thé H
- Issue date: 2007 Mar